Experts discuss opioid use with a focus on validated assessment tools, monitoring strategies, and risk mitigation practices, delving into the complexities of pain scales and emphasizing the need for functional assessments.
Health care professionals discuss navigating challenges in opioid management, emphasizing a patient-centric approach, and address barriers and differences among opioid misuse, abuse, and use disorder.
Expert panelists provide an overview of adverse events associated with bispecific antibodies for the treatment of multiple myeloma along with best practices for monitoring and treating adverse events.
Robert Mancini, PharmD, reviews pharmacists’ pivotal role in operationalizing use of bispecifics in diffuse large B-cell lymphoma (DLBCL), overcoming challenges, and supporting direct patient care teams.
Experts discuss strategies to reduce treatment-related toxicities in bispecific antibody treatments, emphasizing clarity on dosing, hydration, and safety concerns.